Skip to main navigation Skip to search Skip to main content

Correction: Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress (Cell Death & Disease, (2020), 11, 1, (28), 10.1038/s41419-019-2214-9)

  • Kai Wang
  • , Chuanjiang Li
  • , Xinxin Lin
  • , Hang Sun
  • , Ruijuan Xu
  • , Qingping Li
  • , Yiran Wei
  • , Yiyi Li
  • , Jianping Qian
  • , Cuiting Liu
  • , Qifan Zhang
  • , Sheng Yu
  • , Zhonglin Cui
  • , Xixin Huang
  • , Bili Zhu
  • , Jie Zhou
  • , Cungui Mao
  • Southern Medical University
  • Stony Brook University

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

In the original published version of the article, there was a mistake in the affiliations: The first affiliation (“Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China”) should read “Division of Hepatobiliopancreatic Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China” This has been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish
Article number191
JournalCell Death and Disease
Volume11
Issue number3
DOIs
StatePublished - Mar 1 2020

Fingerprint

Dive into the research topics of 'Correction: Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress (Cell Death & Disease, (2020), 11, 1, (28), 10.1038/s41419-019-2214-9)'. Together they form a unique fingerprint.

Cite this